XML 43 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
DERIVATIVE INSTRUMENTS
9 Months Ended
Sep. 30, 2015
DERIVATIVE INSTRUMENTS  
DERIVATIVE INSTRUMENTS

 

12.DERIVATIVE INSTRUMENTS

 

The warrants issued in connection with the Company’s May 2014 public offering have anti-dilution protection provisions that allow for the reduction in the exercise price of the warrants if the Company subsequently issues equity securities, including common stock or any security convertible or exchangeable for shares of common stock, for no consideration or for consideration less than the exercise price of the warrants. Accordingly, these warrants are accounted for as derivative liabilities. The Company used the Binomial Lattice option pricing model and assumptions that consider, among other factors, the fair value of the underlying stock, risk-free interest rate, volatility, expected life and dividend rates in estimating fair value for the warrants considered to be derivative instruments. Changes in fair value of the derivative financial instruments are recognized in the Company’s consolidated statement of operations as a derivative gain or loss. The warrant derivative gains (losses) are non-cash income (expenses); and for the nine months ended September 30, 2015 and 2014 a gain (loss) of $(11,349) and $4,132, respectively, were included in other income (expense) in the Company’s consolidated statement of operations.

 

 

 

September 30,
2015

 

Risk-free interest rate

 

0.33 

%

Expected dividend yield

 

0.00 

%

Expected term (in years)

 

3.61 

 

Expected volatility

 

95.05 

%

 

The primary underlying risk exposure pertaining to the warrants is the change in fair value of the underlying Common Stock for each reporting period.

 

Changes in the derivative warrant liability for the nine months ended September 30 are as follows (in thousands):

 

 

 

Nine Months Ended September 30,

 

 

 

2015

 

2014

 

Balance at December 31,

 

$

7,224

 

$

 

Fair value of warrants issued

 

 

6,848

 

Reduction in derivative liability due to exercise of warrants

 

(16,122

)

 

Increase (decrease) in the fair value of warrants

 

11,349

 

(4,132

)

 

 

 

 

 

 

Balance at September 30,

 

$

2,451

 

$

2,716